- Home
- AEIS vs MRUS Comparison
AEIS vs MRUS Comparison
Compare AEIS & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEIS
- MRUS
- Stock Information
- Founded
- AEIS 1981
- MRUS 2003
- Country
- AEIS United States
- MRUS Netherlands
- Employees
- AEIS N/A
- MRUS N/A
- Industry
- AEIS Industrial Machinery/Components
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- AEIS Technology
- MRUS Health Care
- Exchange
- AEIS Nasdaq
- MRUS Nasdaq
- Market Cap
- AEIS 5.3B
- MRUS 5.1B
- IPO Year
- AEIS 1995
- MRUS 2016
- Fundamental
- Price
- AEIS $156.74
- MRUS $68.09
- Analyst Decision
- AEIS Buy
- MRUS Strong Buy
- Analyst Count
- AEIS 10
- MRUS 13
- Target Price
- AEIS $140.70
- MRUS $90.92
- AVG Volume (30 Days)
- AEIS 298.2K
- MRUS 596.7K
- Earning Date
- AEIS 10-29-2025
- MRUS 10-30-2025
- Dividend Yield
- AEIS 0.25%
- MRUS N/A
- EPS Growth
- AEIS N/A
- MRUS N/A
- EPS
- AEIS 2.22
- MRUS N/A
- Revenue
- AEIS $1,635,742,000.00
- MRUS $56,228,000.00
- Revenue This Year
- AEIS $19.29
- MRUS $57.42
- Revenue Next Year
- AEIS $7.24
- MRUS $0.23
- P/E Ratio
- AEIS $70.83
- MRUS N/A
- Revenue Growth
- AEIS 8.49
- MRUS 59.77
- 52 Week Low
- AEIS $75.01
- MRUS $33.19
- 52 Week High
- AEIS $163.08
- MRUS $70.65
- Technical
- Relative Strength Index (RSI)
- AEIS 57.98
- MRUS 56.09
- Support Level
- AEIS $151.95
- MRUS $65.74
- Resistance Level
- AEIS $161.42
- MRUS $70.65
- Average True Range (ATR)
- AEIS 4.03
- MRUS 2.49
- MACD
- AEIS 0.23
- MRUS 0.03
- Stochastic Oscillator
- AEIS 72.99
- MRUS 67.41
About AEIS Advanced Energy Industries Inc.
Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.